AnsaldoE, FarleyTK, BelkaidY. Control of immunity by the microbiota. Annu Rev Immunol, 2021; 39:449–479; doi: 10.1146/annurev-immunol-093019-112348
2.
ArtisD. A conversation with Dr. David Artis. J Interferon Cytokine Res, 2022; 42(9):449–452; doi: 10.1089/jir.2022.29040.dar
3.
BaeJ, ParkK, KimYM. Commensal microbiota and cancer immunotherapy: Harnessing commensal bacteria for cancer therapy. Immune Netw, 2022; 22(1):e3; doi: 10.4110/in.2022.22.e3
4.
BarbetG, Nair-GuptaP, SchotsaertM, et al.TAP dysfunction in dendritic cells enables noncanonical cross-presentation for T cell priming. Nat Immunol, 2021; 22(4):497–509; doi: 10.1038/s41590-021-00903-7
5.
BrownGJ, CañetePF, WangH, et al.TLR7 gain-of-function genetic variation causes human lupus. Nature, 2022; 605(7909):349–356; doi: 10.1038/s41586-022-04642-z
6.
CautivoKM, MatatiaPR, LizamaCO, et al.Interferon gamma constrains type 2 lymphocyte niche boundaries during mixed inflammation. Immunity, 2022; 55(2):254–271.e7; doi: 10.1016/j.immuni.2021.12.014
7.
ChenW. A conversation with Dr. Wanjun Chen. J Interferon Cytokine Res, 2022; 42(9):453–455; doi: 10.1089/jir.2022.29041.dlw
8.
Domínguez-AndrésJ, Dos SantosJC, BekkeringS, et al.Trained immunity: Adaptation within innate immune mechanisms. Physiol Rev, 2023; 103(1):313–346; doi: 10.1152/physrev.00031.2021
9.
FisherDG, GnazzoV, HolthausenDJ, et al.Non-standard viral genome-derived RNA activates TLR3 and type I IFN signaling to induce cDC1-dependent CD8+ T-cell responses during vaccination in mice. Vaccine, 2022; 40(50):7270–7279; doi: 10.1016/j.vaccine.2022.10.052
10.
GernerRR, HossainS, SargunA, et al.Siderophore immunization restricted colonization of adherent-invasive Escherichia coli and ameliorated experimental colitis. mBio, 2022; 13(5):e0218422; doi: 10.1128/mbio.02184-22
11.
GlassmanCR, TsutsumiN, SaxtonRA, et al.Structure of a Janus kinase cytokine receptor complex reveals the basis for dimeric activation. Science, 2022; 376(6589):163–169; doi: 10.1126/science.abn8933
12.
GreeneTT, ZunigaEI. Type I interferon induction and exhaustion during viral infection: plasmacytoid dendritic cells and emerging COVID-19 findings. Viruses, 2021; 13(9):1839; doi: 10.3390/v13091839
13.
GschwendJ, ShermanSPM, RidderF, et al.Alveolar macrophages rely on GM-CSF from alveolar epithelial type 2 cells before and after birth. J Exp Med, 2021; 218(10):e20210745; doi: 10.1084/jem.20210745
14.
HaganT, GerritsenB, TomalinLE, et al.Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses. Nat Immunol, 2022; 23(12):1788–1798; doi: 10.1038/s41590-022-01328-6
15.
KobayashiT, MoroK. Tissue-specific diversity of group 2 innate lymphoid cells in the skin. Front Immunol, 2022; 13:885642; doi: 10.3389/fimmu.2022.885642
16.
LiZ, LiuW, FuJ, et al.Shigella evades pyroptosis by arginine ADP-riboxanation of caspase-11. Nature, 2021; 599(7884):290–295; doi: 10.1038/s41586-021-04020-1
17.
Lima-JuniorDS, KrishnamurthySR, BouladouxN, et al.Endogenous retroviruses promote homeostatic and inflammatory responses to the microbiota. Cell, 2021; 184(14):3794–3811.e19; doi: 10.1016/j.cell.2021.05.020
18.
LiuX, BoyerMA, HolmgrenAM, et al.Legionella-infected macrophages engage the alveolar epithelium to metabolically reprogram myeloid cells and promote antibacterial inflammation. Cell Host Microbe, 2020; 28(5):683–698.e6; doi: 10.1016/j.chom.2020.07.019
LopesN, McIntyreC, MartinS, et al.Distinct metabolic programs established in the thymus control effector functions of γδ T cell subsets in tumor microenvironments. Nat Immunol, 2021; 22(2):179–192; doi: 10.1038/s41590-020-00848-3
21.
Martinez-SanchezN, SweeneyO, Sidarta-OliveiraD, et al.The sympathetic nervous system in the 21st century: Neuroimmune interactions in metabolic homeostasis and obesity. Neuron, 2022; 110(21):3597–3626; doi: 10.1016/j.neuron.2022.10.017
22.
RathnasingheR, SalvatoreM, ZhengH, et al.Interferon mediated prophylactic protection against respiratory viruses conferred by a prototype live attenuated influenza virus vaccine lacking non-structural protein 1. Sci Rep, 2021; 11(1):22164; doi: 10.1038/s41598-021-01780-8
23.
RivasMN, PorrittRA, ChengMH, et al.Multisystem inflammatory syndrome in children and long COVID: The SARS-CoV-2 viral superantigen hypothesis. Front Immunol, 2022; 13:941009; doi: 10.3389/fimmu.2022.941009
24.
RodriguesTS, de SáKSG, IshimotoAY, et al.Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J Exp Med, 2021; 218(3):e20201707; doi: 10.1084/jem.20201707
25.
WalkerFC, SridharPR, BaldridgeMT. Differential roles of interferons in innate responses to mucosal viral infections. Trends Immunol, 2021; 42(11):1009–1023; doi: 10.1016/j.it.2021.09.003
26.
WangL, TangJ, YangX, et al.TGF-β induces ST2 and programs ILC2 development. Nat Commun, 2020; 11(1):35; doi: 10.1038/s41467-019-13734-w
YamadaT, SatoS, SotoyamaY, et al.RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells. Nat Immunol, 2021; 22(7):820–828; doi: 10.1038/s41590-021-00942-0
YoshimuraA, ItoM, Mise-OmataS, et al.SOCS: Negative regulators of cytokine signaling for immune tolerance. Int Immunol, 2021; 33(12):711–716; doi: 10.1093/intimm/dxab055
31.
YueP, ZhuY, Brotherton-PleissC, et al.Novel potent azetidine-based compounds irreversibly inhibit Stat3 activation and induce antitumor response against human breast tumor growth in vivo. Cancer Lett, 2022; 534:215613; doi: 10.1016/j.canlet.2022.215613
32.
ZhangQ, MatuozzoD, Le PenJ, et al.Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia. J Exp Med, 2022; 219(8):e20220131; doi: 10.1084/jem.20220131
